End-of-day quote
BURSA MALAYSIA
18:00:00 2024-05-05 EDT
|
5-day change
|
1st Jan Change
|
0.335
MYR
|
-4.29%
|
|
0.00%
|
-12.99%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
724.2
|
538.1
|
1,309
|
969.4
|
713.9
|
482.8
|
482.8
|
-
|
Enterprise Value (EV)
1 |
724.2
|
538.1
|
1,309
|
969.4
|
713.9
|
554.9
|
482.8
|
482.8
|
P/E ratio
|
17.1
x
|
-3.6
x
|
47.6
x
|
5.63
x
|
-1.18
x
|
-6.8
x
|
10.8
x
|
10.5
x
|
Yield
|
5.76%
|
4.13%
|
2.2%
|
12.6%
|
3.49%
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.3
x
|
0.19
x
|
0.48
x
|
0.2
x
|
0.2
x
|
0.16
x
|
0.14
x
|
0.14
x
|
EV / Revenue
|
0.3
x
|
0.19
x
|
0.48
x
|
0.2
x
|
0.2
x
|
0.16
x
|
0.14
x
|
0.14
x
|
EV / EBITDA
|
4.72
x
|
4.12
x
|
12.9
x
|
2.83
x
|
-1.41
x
|
14.1
x
|
-
|
-
|
EV / FCF
|
-4.68
x
|
4.64
x
|
-31.1
x
|
-10.3
x
|
-3.54
x
|
-59.7
x
|
21.3
x
|
-
|
FCF Yield
|
-21.4%
|
21.6%
|
-3.21%
|
-9.74%
|
-28.2%
|
-1.68%
|
4.7%
|
-
|
Price to Book
|
1.42
x
|
1.59
x
|
3.88
x
|
2.15
x
|
-2.87
x
|
-1.78
x
|
-1.97
x
|
-2.39
x
|
Nbr of stocks (in thousands)
|
1,302,525
|
1,306,149
|
1,308,529
|
1,309,959
|
1,309,959
|
1,441,230
|
1,441,230
|
-
|
Reference price
2 |
0.5560
|
0.4120
|
1.000
|
0.7400
|
0.5450
|
0.3350
|
0.3350
|
0.3350
|
Announcement Date
|
19-02-21
|
20-02-20
|
21-03-17
|
22-02-17
|
23-02-27
|
24-02-29
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,385
|
2,821
|
2,725
|
4,815
|
3,511
|
3,404
|
3,336
|
3,503
|
EBITDA
1 |
153.5
|
130.6
|
101.2
|
342.3
|
-505.3
|
39.24
|
-
|
-
|
EBIT
1 |
105.4
|
-153
|
68.86
|
308.9
|
-541.7
|
-5.106
|
-
|
-
|
Operating Margin
|
4.42%
|
-5.42%
|
2.53%
|
6.41%
|
-15.43%
|
-0.15%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
70.22
|
-191.9
|
35.79
|
277.1
|
-580.8
|
-62.82
|
70.7
|
72.6
|
Net income
1 |
42.47
|
-149.2
|
27.49
|
172.2
|
-607.3
|
-77.45
|
45
|
46.2
|
Net margin
|
1.78%
|
-5.29%
|
1.01%
|
3.58%
|
-17.3%
|
-2.28%
|
1.35%
|
1.32%
|
EPS
2 |
0.0326
|
-0.1144
|
0.0210
|
0.1315
|
-0.4636
|
-0.0566
|
0.0310
|
0.0320
|
Free Cash Flow
1 |
-154.7
|
116
|
-42.04
|
-94.44
|
-201.6
|
-9.295
|
22.7
|
-
|
FCF margin
|
-6.49%
|
4.11%
|
-1.54%
|
-1.96%
|
-5.74%
|
-0.27%
|
0.68%
|
-
|
FCF Conversion (EBITDA)
|
-
|
88.83%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
50.44%
|
-
|
Dividend per Share
2 |
0.0320
|
0.0170
|
0.0220
|
0.0930
|
0.0190
|
-
|
-
|
-
|
Announcement Date
|
19-02-21
|
20-02-20
|
21-03-17
|
22-02-17
|
23-02-27
|
24-02-29
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-155
|
116
|
-42
|
-94.4
|
-202
|
-9.3
|
22.7
|
-
|
ROE (net income / shareholders' equity)
|
8.19%
|
-35.2%
|
8.14%
|
43.7%
|
-
|
-25.5%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
2.41%
|
-8.53%
|
1.73%
|
8.97%
|
-29.8%
|
-4.13%
|
-
|
-
|
Assets
1 |
1,763
|
1,750
|
1,586
|
1,919
|
2,038
|
1,875
|
-
|
-
|
Book Value Per Share
2 |
0.3900
|
0.2600
|
0.2600
|
0.3400
|
-0.1900
|
-0.2200
|
-0.1700
|
-0.1400
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
71.9
|
72.7
|
9.25
|
30.4
|
59.3
|
-
|
-
|
-
|
Capex / Sales
|
3.01%
|
2.58%
|
0.34%
|
0.63%
|
1.69%
|
-
|
-
|
-
|
Announcement Date
|
19-02-21
|
20-02-20
|
21-03-17
|
22-02-17
|
23-02-27
|
24-02-29
|
-
|
-
|
Last Close Price
0.335
MYR Average target price
0.31
MYR Spread / Average Target -7.46% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.99% | 102M | | +15.21% | 70.09B | | -2.19% | 24.01B | | +8.13% | 8.32B | | -18.28% | 8.23B | | 0.00% | 8.08B | | +19.12% | 4.41B | | 0.00% | 4.12B | | -3.02% | 3.88B | | +23.97% | 3.71B |
Pharmaceuticals Wholesale
|